Hikma Launches Long-Awaited US Advair Rival
Competes With Viatris’ Wixela Inhub, But Not In All Strengths
Hikma has gained FDA approval for and launched its long-in-development generic version of Advair Diskus. The milestone puts it in direct competition with Viatris’ Wixela Inhub version that was launched almost two years ago, in three presentations compared to Hikma’s two.
